CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


topical steroids and cyclosporin-AWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)


Name (Synonyms) Correlation

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D007637 Keratoconjunctivitis NIH 1.00

Correlated HPO Terms (1)


Name (Synonyms) Correlation
HP:0001096 Keratoconjunctivitis HPO 1.00

There is one clinical trial.

Clinical Trials


1 Combined Topical Corticosteroid and Topical Cyclosporine-A for Management of COVID-19 Keratoconjunctivitis; a Pilot Study

To explore the feasibility of combined topical corticosteroid and topical cyclosporine-A in COVID-19 patients with acute keratoconjunctivitis.

NCT04451239 Keratonjunctivitis Drug: topical steroids and cyclosporin-A
MeSH:Keratoconjunctivitis
HPO:Keratoconjunctivitis

Primary Outcomes

Description: eye itching, foreign body sensation, tearing, redness in the eye and eyelid swelling

Measure: Symptom improvement

Time: 10-15 days

Description: conjunctival injection, discharge, presence of superficial punctate keratitis (SPK), pseudomembranes on tarsal conjunctiva

Measure: Signs improvement

Time: 10-15 days


Related HPO nodes (Using clinical trials)